confirmed now - Michelle: Hillary Is On Drugs
We thought
confirmed now - Michelle: Hillary Is On Drugs
We thought she had to be on stimulants
Michelle Obama, widely acknowledged as Hillary Clinton’s most effective campaign surrogate, is concerned that the Democrat presidential nominee’s health is so fragile that she depends on stimulant drugs to get her through the grueling race for the White House.
Both Michelle and Barack Obama have been concerned with the state of Hillary’s health since her presidential campaign began. The Obamas know that Hillary suffers from a slew of severe and debilitating health issues, all of which I have exposed in my latest New York Times bestseller Guilty as Sin.
According to a guest who stayed overnight in the White House and was present in the Family Residence during a discussion of Hillary’s health, Barack Obama and Valerie Jarrett, the president’s chief adviser, agreed with the first lady that Hillary has relied on booster drugs during her campaign rallies and three debates with Donald Trump.
They came to that conclusion after a recent meeting with Hillary in the White House, where Hillary made an effort to persuade the president and first lady to coordinate their public appearances with Robby Mook, the Clinton campaign manager.
When Hillary suggested that the president and the first lady submit their speeches in advance to Mook in order to make sure they were on the same page as Hillary’s campaign, Michelle Obama broke out in derisive laughter.
“Michelle made it plain that she and Barack knew how campaigns work better than Hillary or Mook,” said the source who participated in the discussion. “After all, Barack cleaned Hillary’s clock during the 2008 Democratic Party primaries.
“During the heated discussion over campaign coordination,” the source continued, “Hillary suddenly broke out in a coughing fit. The president offered Hillary a glass of water, but Hillary’s coughing only grew worse.
“The president became so alarmed that he summoned one of the five doctors who rotate on duty 24/7 in the White House Medical Unit. The doctor rushed to the Oval Office.”
While the doctor was administering to Hillary, the president, the first lady and Valerie Jarrett stepped outside and turned the Oval Office over to Hillary and the doctor. After a while, the doctor emerged and told everyone that he was able to stop Hillary’s convulsive coughing and that she was all right.
“The experience left the president and first lady shaken and worried,” said the source. “It was clear to them that Hillary was not well. They know how exhausting and draining a presidential campaign is. Clearly, the Hillary they saw in the White House was different than the Hillary the public has seen during her rallies and in the debates.
“They concluded that there was no way that Hillary could make it through such a demanding ordeal without getting some help from booster drugs.”
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Staggering Growth in Loan Originations Ever wake up to an unexpected windfall? That's the kind of headline PenFed Credit Union is writing with its $8.8 billion in year-to-date loan originations by the end of September 2026. Up 22% year-over-year, folks. Those numbers don't just happen by accident. That's hitting the nail on the head in the credit union world. Mortgage and...
Continue Reading
Space Gear Finds a New Home In a move that brings a piece of the cosmos down to Earth, the AstroRad radiation protection vest, used by astronauts aboard the International Space Station (ISS), has landed a spot in the Smithsonian's National Air and Space Museum. It's not just some random hunk of tech; this vest represents a milestone in the annals of space gear — a...
Continue Reading
A Shock to the System: Cooper's Rough Patch Not every day you see a stock take a body slam like this! Cooper Companies (NASDAQ: COO) got walloped after revealing some unsavory truths about its Q3 2026 performance. The market didn't just flinch—it reeled. On September 10, 2026, COO shares dove a steep $9.31—around a 14.6% free fall—whacking off over $1.7 billion in...
Continue Reading
The Green Methanol Boom Folks, the money's about to get greener—greener methanol, that is. We’re talking about a market that’s set to explode from a humble $3.46 billion in 2026 to a jaw-dropping $20.11 billion by 2032. With a hefty CAGR of 34.1%, it seems like investors might want to buckle up for a bullish ride in this eco-friendly venture. Why Green Methanol?...
Continue Reading
Data Breach Fallout Looms Over Del Monte Here's the scoop on Del Monte Foods facing what looks like a data breach debacle of epic proportions. Ransomware has hit the fan, and now folks are scrambling as Edelson Lechtzin LLP gears up to lay down some serious class action heat. From Cyber Shadows to Court Considerations This storm brewed on February 7, 2026. Del Monte’s...
Continue Reading
Cytrellis Partners with University of Miami The announcement from Cytrellis Biosystems is drawing some attention. The company's jumped into a new partnership with the University of Miami School of Nursing and Health Studies, looking to jazz up their Aesthetic Medicine Certificate Program. The kicker here is the introduction of Cytrellis' ellacor® system, a fancy bit of...
Continue Reading
BioArctic's Power Play: A Two-Pronged Update Ever feel like biotechnology is just a series of chess moves? BioArctic's recent maneuvers in the life sciences game certainly hint at that. First, they've got data brewing on lecanemab—this ain't small beans, folks, not with Alzheimer's disease in the crosshairs. Then there's their Nomination Committee. It’s like shaking...
Continue Reading
SCI's Rough Ride: Investors Brace for Impact There's nothing like waking up to find the stock you were banking on took a nosedive while you were dreaming of dividends. Service Corporation International (NYSE: SCI) sure gave shareholders more of a nightmare than a dream, slashing its earnings forecast for 2026 and watching its stock crumble by about 11.6% on October 29....
Continue Reading
Intestinal Worms: A Modern Twist on an Old Tale Just when you thought you'd heard it all, here comes the notion that intestinal worms might actually be good for us. The stuff of cringe-worthy junior high biology classes is now strutting its stuff in F1000Research. Sounds odd? Maybe, but there's a half-century of science behind it. Old Foes with New Friends These...
Continue Reading
Gastops and Bell Seal a Forward-Looking Deal Who would've thought Gastops and Bell, two juggernauts in their respective fields, would link arms to drive the aerospace game forward in Canada? That's right, a Memorandum of Understanding (MOU) was inked between these titans at the 2026 Canadian Aerospace Summit, paving the way for collaboration on future programs. This isn't...
Continue Reading
Top 5 Most Recently Viewed Articles
Vitesse Energy's Third Quarter Highlights Vitesse Energy, Inc. (NYSE: VTS) recently shared its financial and operating results for the third quarter. The company reported a robust net income of $17.4 million alongside an adjusted net income of $7.6 million. The adjusted EBITDA reached $37.6 million, alongside operational cash flow exceeding $45.7 million, showcasing a...
Continue Reading
Capital One's Remarkable Q3 Performance Capital One Financial Corp. (NYSE: COF) recently unveiled its third-quarter results, showcasing a strong financial performance that exceeded analysts' expectations. The report highlighted significant increases in both earnings and revenue, making a substantial impact on investor confidence and stock performance. Diving into the Key...
Continue Reading
Update on Travere Therapeutics On a recent Wednesday, Stifel maintained its Hold rating for Travere Therapeutics (NASDAQ:TVTX) while raising the price target to $13.00 from the previous $10.00. This adjustment is a result of a thorough analysis of the company's recent progress, specifically focusing on their drug candidate, Sparsentan. Significance of the PARASOL Workshop...
Continue Reading
Kahoot! Achieves Gold Certification in Educational Equity Kahoot!, the renowned education technology platform, has recently been awarded the prestigious ICEIE Gold certification for its unwavering commitment to equity in education. This recognition emphasizes the company's dedication to ensuring that all learners have access to quality educational tools and resources,...
Continue Reading
Spicewood Mineral Partners Expands Holdings in the Permian Basin Spicewood Mineral Partners, a prominent mineral and energy investment firm based in Dallas, has made exciting updates regarding its latest acquisitions in the Delaware Basin. The company has recently targeted a selection of high-quality "tier 1" mineral assets in the Permian Basin, showcasing a strategic...
Continue Reading